Ball Robert Joseph
Known title: CEO & EXECUTIVE CHAIRMANCIK: 0002070664
Ball Robert Joseph's purchase track record
How the stock did after each of Ball Robert Joseph's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since September 11, 2025
Stock higher 6 months later
67%
3 months: 33%
Median 6-month return
+25.0%
3 months: -0.4%
Beat the S&P 500
67%
median +9.6% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/13/2026 | SI | $33K | +26.2% | +25.0% | +15.4% |
| 12/11/2025 | SI | $107K | -2.1% | +25.6% | +7.1% |
| 9/11/2025 | SI | $123K | -0.4% | -2.5% | +1.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SI | ▲ Buy | Option Exercise | 89,233 | $187K | 9/14/2026 | View on chart |
| SI | ▼ Sell | Open Market | 10,175 | $188K | 9/14/2026 | View on chart |
| SI | ▲ Buy | Option Exercise | 10,000 | $25K | 4/30/2026 | View on chart |
| SI | ▲ Buy | Open Market | 2,200 | $33K | 3/13/2026 | View on chart |
| SI | ▲ Buy | Option Exercise | 10,000 | $25K | 2/6/2026 | View on chart |
| SI | ▲ Buy | Option Exercise | 2,062 | $4K | 2/6/2026 | View on chart |
| SI | ▲ Buy | Grant | 1,661 | $20K | 12/31/2025 | View on chart |
| SI | ▲ Buy | Open Market | 3,900 | $58K | 12/12/2025 | View on chart |
| SI | ▲ Buy | Open Market | 3,300 | $49K | 12/11/2025 | View on chart |
| SI | ▲ Buy | Open Market | 6,000 | $93K | 9/12/2025 | View on chart |
| SI | ▲ Buy | Open Market | 2,000 | $30K | 9/11/2025 | View on chart |
| SI | ▼ Sell | Other | 85,888 | — | 8/1/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Shoulder Innovations Q2 2026 earnings and BTIG target raise
Shoulder Innovations held its Q2 2026 earnings conference call, where management discussed the quarter’s results. BTIG analyst kept its rating on the stock and increased the price target to $27. The new target is above the current average analyst estimate of $26.25 and above the 52‑week high of $24.59.
Shoulder Innovations Q2 2026 earnings and BTIG target raise. Shoulder Innovations held its Q2 2026 earnings conference call, where management discussed the quarter’s results. BTIG analyst kept its rating on the stock and increased the price target to $27. The new target is above the current average analyst estimate of $26.25 and above the 52‑week high of $24.59.